自然成分的研究进展 通过调节氧化应激来改善帕金森病
Wei Jiang1,2,3, Zifa Li1,2,3, Minghui Hu1,2,3
1Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan, China.
Phytotherapy research : PTR
|February 2, 2026
概括
天然化合物通过向氧化压力,显示出对抗帕金森病 (PD) 的承诺. 需要进一步的临床试验来确认这些神经保护剂对帕金森病患者的疗效.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,治疗选择有限.
- 氧化应激是PD病变发生的一个关键因素,使其成为一个重要的治疗点.
- 目前的PD治疗提供症状缓解,但不能阻止疾病的进展.
研究的目的:
- 审查具有对帕金森病潜在神经保护作用的天然化合物.
- 综合当前关于这些天然化合物的作用机制的知识.
- 引导未来的研究和开发PD的新型治疗策略.
主要方法:
- 对自然化合物和PD的临床前研究 (体外和体内) 的审查.
- 对这些化合物的神经保护作用背后的分子机制的分析.
- 综合各种自然化合物类别的证据,包括多,黄,糖化物,类和类.
主要成果:
- 选择的天然化合物显示出调节PD中涉及的氧化应激的能力.
- 临床前数据表明,各种天然化合物的神经保护潜力.
- 这些天然化合物在人类的临床疗效的证据仍然有限.
结论:
- 自然化合物代表了在帕金森病中新的治疗策略的有希望的途径.
- 严格,高质量的临床试验对于验证这些化合物的有效性和安全性至关重要.
- 需要进一步的研究来将临床前发现转化为PD管理的有效临床实践.
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34

